SCHEMBL3098068

SCHEMBL3098068

O[C@@H]1CCC[C@@H](O)CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1115888 1.00
SCHEMBL3098062 1.00
SCHEMBL13888940 1.00
SCHEMBL1821097 0.95 TSHR (0.82)
SCHEMBL11691617 0.95 TSHR (0.82)
SCHEMBL328907 0.95 TSHR (0.82)
SCHEMBL9225512 0.95 TSHR (0.82)
SCHEMBL9215694 0.91 TSHR (0.91)
SCHEMBL15832112 0.91 TSHR (0.91)
SCHEMBL11324930 0.91 TSHR (0.91)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250368983-A1 CONTROLLING FOR TAGMENTATION SEQUENCING LIBRARY INSERT SIZE USING ARCHAEAL HISTONE-LIKE PROTEINS KAPA BIOSYSTEMS INC (US) 2025-12-04 US disclosed
WO-2024046992-A1 IMPROVEMENTS TO NEXT-GENERATION TARGET ENRICHMENT PERFORMANCE F. HOFFMANN-LA ROCHE AG (CH) 2024-03-07 WO disclosed
WO-2024003332-A1 CONTROLLING FOR TAGMENTATION SEQUENCING LIBRARY INSERT SIZE USING ARCHAEAL HISTONE-LIKE PROTEINS F. HOFFMANN-LA ROCHE AG (CH) 2024-01-04 WO disclosed
EP-3149446-B1 FIXATIVE COMPOSITION FOR CELL-COMPRISING LIQUID SAMPLES QIAGEN GMBH (DE) 2022-07-06 EP disclosed
US-20210389216-A1 FIXATION OF A BIOLOGICAL MATERIAL QIAGEN GMBH (DE) 2021-12-16 US disclosed
US-20210381937-A1 FIXATION OF A BIOLOGICAL MATERIAL QIAGEN GMBH (DE) 2021-12-09 US disclosed
US-10794803-B2 Fixative composition for cell-comprising liquid samples and methods and kit thereof QIAGEN GMBH (DE) 2020-10-06 US disclosed
US-20170052095-A1 Fixative Composition for Cell-Comprising Liquid Samples QIAGEN GMBH (DE) 2017-02-23 US disclosed
EP-2126542-B1 FIXATION OF A BIOLOGICAL MATERIAL QIAGEN GMBH (DE) 2016-11-02 EP disclosed
US-8796028-B2 Method for treating a biological sample with a composition containing at least one polyol and excluding water QIAGEN GMBH (DE) 2014-08-05 US disclosed
US-20100173295-A1 FIXATION OF A BIOLOGICAL MATERIAL QIAGEN GMBH (DE) 2010-07-08 US disclosed
US-20100009349-A1 Method for Treating a Biological Sample QIAGEN GMBH (DE) 2010-01-14 US disclosed
EP-2048167-A2 First catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer Sumitomo Chemical Company, Limited (JP) 2009-04-15 EP disclosed
EP-2048168-A2 Process for producing catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer Sumitomo Chemical Company, Limited (JP) 2009-04-15 EP disclosed
EP-2048169-A2 Third catalyst component for addition polymerization, catalyst for addition polymerization, and process for producing addition polymer Sumitomo Chemical Company, Limited (JP) 2009-04-15 EP disclosed
EP-1965190-A1 Fixation of a biological sample Qiagen GmbH (DE) 2008-09-03 EP disclosed